Bogart Wealth LLC’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.5K Buy
169
+38
+29% +$3.33K ﹤0.01% 895
2026
Q1
$11.8K Buy
131
+11
+9% +$1.01K ﹤0.01% 868
2025
Q4
$10.8K Hold
120
﹤0.01% 850
2025
Q3
$11.8K Hold
120
﹤0.01% 795
2025
Q2
$10.9K Sell
120
-5
-4% -$483 ﹤0.01% 780
2025
Q1
$14.1K Sell
125
-95
-43% -$10.2K ﹤0.01% 674
2024
Q4
$23.2K Buy
220
+100
+83% +$10.7K ﹤0.01% 554
2024
Q3
$13K Sell
120
-10
-8% -$1.09K ﹤0.01% 635
2024
Q2
$14.1K Sell
130
-13
-9% -$1.53K ﹤0.01% 597
2024
Q1
$18.8K Buy
143
+10
+8% +$1.25K ﹤0.01% 526
2023
Q4
$16.2K Hold
133
﹤0.01% 540
2023
Q3
$14.9K Hold
133
﹤0.01% 524
2023
Q2
$19.3K Buy
133
+120
+923% +$16.3K ﹤0.01% 471
2023
Q1
$1.63K Sell
13
-11
-46% -$1.38K ﹤0.01% 934
2022
Q4
$3.03K Buy
24
+11
+85% +$1.28K ﹤0.01% 748
2022
Q3
$1K Hold
13
﹤0.01% 963
2022
Q2
$1K Buy
13
+1
+8% +$119 ﹤0.01% 880
2022
Q1
$2K Sell
12
-1
-8% -$121 ﹤0.01% 715
2021
Q4
$2K Buy
+13
New +$1.7K ﹤0.01% 681

Other funds holding ZBH

Bogart Wealth LLC's ZBH Position: Q2 2026 in Review

Bogart Wealth LLC increased its Zimmer Biomet (ZBH) stake by 29% in Q2 2026, buying an estimated $3.33K and bringing the position to 169 shares worth $14.5K. The position accounts for ﹤0.01% of the portfolio, ranked #895.

Bogart Wealth LLC first reported a position in ZBH in Q4 2021 and has held it in 19 quarters since. The position peaked at $23.2K in Q4 2024. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Bogart Wealth LLC held 169 shares of Zimmer Biomet worth $14.5K as of Q2 2026.
  • Bogart Wealth LLC bought 38 Zimmer Biomet shares in Q2 2026, an estimated $3.33K.
  • Zimmer Biomet made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #895 holding.
  • Bogart Wealth LLC first reported a position in Zimmer Biomet in Q4 2021 and has held it in 19 quarters since.
  • Bogart Wealth LLC's Zimmer Biomet position peaked at $23.2K in Q4 2024.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.